ViroPharma, Inc. (NASDAQ:VPHM.DL)

CAPS Rating: No stars

A biopharmaceutical company dedicated to the development and commercialization of products that address serious infectious diseases, with a focus on products used by physician specialists or in hospital settings.

Recs

1
Player Avatar rmbashir (< 20) Submitted: 9/26/2006 6:02:09 AM : Underperform Start Price: $12.58 VPHM.DL Score: -259.17

NO SOLID PHASE 3 TRIALS.
HAVE MANY FAILURES IN THE PIPELINE; ALOT OF COMPETETION FOR HEP C, INCLUDING INGENIX AND SCHERING WITH PROTEASE INHIBITORS COMING OUT. NEED NEW BLOOD COARSING THROUGH ITS VEINS OR COULD SETTLE IN AT 11-13.

Member Avatar RRobertsmith (56.40) Submitted: 8/15/2011 10:59:07 AM
Recs: 0

another perfectly good review ruined because of all caps,,,reminds me of an old teletype with only one type face....
http://www.youtube.com/watch?v=eyCEexG9xjw

Featured Broker Partners


Advertisement